9.19
+0.09
+(0.99%)
At close: 4:00:00 PM EDT
9.19
0.00
(0.00%)
After hours: 4:00:11 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
78,226
78,226
70,987
76,276
74,652
Cost of Revenue
7,231
7,231
8,633
9,263
9,151
Gross Profit
70,995
70,995
62,354
67,013
65,501
Operating Expense
87,314
87,314
85,102
122,909
131,951
Operating Income
-16,319
-16,319
-22,748
-55,896
-66,450
Net Non Operating Interest Income Expense
-17,309
-17,309
-17,001
-16,330
-15,921
Other Income Expense
12,087
12,087
4,266
-2,607
75
Pretax Income
-21,541
-21,541
-35,483
-74,833
-82,296
Net Income Common Stockholders
-21,541
-21,541
-35,483
-74,833
-82,296
Diluted NI Available to Com Stockholders
-21,541
-21,541
-35,483
-74,833
-82,296
Basic EPS
-2.12
-2.12
-4.75
-13.05
-21.75
Diluted EPS
-2.12
-2.12
-4.75
-13.05
-21.75
Basic Average Shares
10,156.75
10,156.75
7,472.04
5,726.68
3,790.13
Diluted Average Shares
10,156.75
10,156.75
7,472.04
5,726.68
3,790.13
Total Operating Income as Reported
-16,319
-16,319
-22,748
-55,896
-66,450
Total Expenses
94,545
94,545
93,735
132,172
141,102
Net Income from Continuing & Discontinued Operation
-21,541
-21,541
-35,483
-74,833
-82,296
Normalized Income
-21,541
-21,541
-35,483
-73,622
-82,296
Interest Income
2,751
2,751
2,527
513
52
Interest Expense
20,060
20,060
19,528
16,843
15,973
Net Interest Income
-17,309
-17,309
-17,001
-16,330
-15,921
EBIT
-1,481
-1,481
-15,955
-57,990
-66,323
EBITDA
-1,198
-1,198
-15,553
-57,458
-65,677
Reconciled Cost of Revenue
7,231
7,231
8,633
9,263
9,151
Reconciled Depreciation
283
283
402
532
646
Net Income from Continuing Operation Net Minority Interest
-21,541
-21,541
-35,483
-74,833
-82,296
Total Unusual Items Excluding Goodwill
--
--
4,290
-1,211
--
Total Unusual Items
--
--
4,290
-1,211
--
Normalized EBITDA
-1,198
-1,198
-15,553
-56,247
-65,677
12/31/2021 - 10/13/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ANIK Anika Therapeutics, Inc.
13.72
-1.22%
INDV Indivior PLC
9.11
-3.50%
AYTU Aytu BioPharma, Inc.
1.0400
+2.97%
AVDL Avadel Pharmaceuticals plc
7.91
+2.33%
LFCR Lifecore Biomedical, Inc.
6.25
+1.30%
AMRX Amneal Pharmaceuticals, Inc.
7.17
-0.55%
DERM Journey Medical Corporation
6.18
-0.48%
KABRADG.BO Kabra Drugs Limited
11.08
0.00%
CPIX Cumberland Pharmaceuticals Inc.
4.1000
-2.15%
INNPF InnoCan Pharma Corporation
0.1400
0.00%